We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Some Government Contracts for COVID-19 Products Dodge Affordable Pricing Laws, Report Says
Some Government Contracts for COVID-19 Products Dodge Affordable Pricing Laws, Report Says
At least five drug developers working on COVID-19 therapeutics and vaccines with U.S. government funding have contracts that bypass laws that ensure taxpayer-funded drugs and vaccines are affordable, a new report says.